LEISHMANIA

Every year, with an estimated 1.3 million new cases and more than 20,000 deaths, Leishmaniasis continues to be a menace in countries across the globe. With the absence of an anti-Leishmania vaccine - along with the toxicity of current anti-parasite drugs and coupled with the rapid emergence of drug resistant Leishmania strains - there remains significant challenges for disease control. This has spurred a plethora of research initiatives into parasite biology, parasite-host interaction, mechanisms of disease pathogenesis, drug development, and the molecular mechanism of drug resistance. Insights obtained from various studies are essential for the development of novel anti-Leishmania treatment strategies. In this timely book, respected Leishmania experts distil important current research, highlighting the most insightful discoveries in the field. Topics covered include